YONKERS, N.Y., October 3 /CNW/ - A new Phase II open label study at McGill University will explore the effect of an investigational drug on patients with recurrent or advanced cancer....
Advanced Viral Research Corp. (OTCBB:ADVR), a research based biopharmaceutical company dedicated to anti-cancer drug discovery and development, announced today plans to initiate a Phase...
YONKERS, N.Y.--(BUSINESS WIRE)--First graph, third sentence of release should read: $1,000,000 of the
debentures and the warrants were sold on January 5, 2007... (sted
$1,000,000 of...
YONKERS, N.Y.--(BUSINESS WIRE)--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a
bio-pharmaceutical company, announced today that it has filed an
amendment with the FDA to...
YONKERS, N.Y.--(BUSINESS WIRE)--Aug. 10, 2006--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that following an interim analysis of 30...
YONKERS, N.Y.--(BUSINESS WIRE)--Aug. 7, 2006--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that a wound healing study topically applying...
YONKERS, N.Y.--(BUSINESS WIRE)--July 17, 2006--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) a bio-pharmaceutical company, announced today that effective June 27, 2006, the company has...
YONKERS, N.Y.--(BUSINESS WIRE)--Oct. 3, 2005--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) announced today that it has initiated a Phase I, Double Blind, Placebo Controlled, Randomized,...
YONKERS, N.Y.--(BUSINESS WIRE)--July 26, 2005--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) announced today that the U.S. Patent and Trademark Office has issued the Company U.S. Patent...
YONKERS, N.Y.--(BUSINESS WIRE)--July 13, 2005--Advanced Viral Research Corp. (OTC Bulletin Board: ADVR) announced today the addition of Queens Medical Associates in New York as a new clinical site...
ADVR Advanced Viral Research Corp., incorporated in July 1985, is
primarily engaged in the production and marketing, promotion and sale
of a pharmaceutical drug known by the trademark Reticulose....